Science Explorer Back to mapMap
Discussion
Researcher · Caris Life Sciences (United States) · United States

Matthew James Oberley

Matthew James Oberley publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers and Acute Lymphoblastic Leukemia research.

ORCID 0000-0001-6419-2513 OpenAlex
World rank
#235,415
of 7,710,434 ranked researchers
Rank in United States
#86,839
of 1,627,098
Works
377
Citations
3.5k
Citations per work
9.2
h-index
31
i10-index 62Top 11% in Oncology
Matthew James Oberley

What does Matthew James Oberley research?

Matthew James Oberley's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (21%).

Health Sciences: 164 works · 43.5% of their workMedicine: 164 works · 43.5% of their workOncology: 75 works · 19.8% of their workPulmonary and Respiratory Medicine: 51 works · 13.5% of their workPathology and Forensic Medicine: 23 works · 6.0% of their workSurgery: 16 works · 4.2% of their workEverything else: 135 works · 35.8% of their workLife Sciences: 78 works · 20.7% of their workBiochemistry, Genetics and Molecular Biology: 78 works · 20.7% of their workMolecular Biology: 41 works · 10.9% of their workCancer Research: 37 works · 9.8% of their workTHEIR WORKMatthew JamesOberley377works
Life Sciences21%Health Sciences44%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine16443.5%
  2. Everything else13535.8%
    1. Biochemistry, Genetics and Molecular Biology7820.7%
  1. 1Oncology20% of their works
  2. 2Pulmonary and Respiratory Medicine14% of their works
  3. 3Molecular Biology11% of their works
  4. 4Cancer Research10% of their works
  5. 5Pathology and Forensic Medicine6% of their works
  6. 6Surgery4% of their works

Research topics

Which keywords describe Matthew James Oberley's research?

The keywords of their largest research topics: Targeted Therapy, Cancer Genomics, Mutational Signatures, Prognostic Factors, Immune Checkpoint Blockade, PD-1 and PD-L1, Acute Lymphoblastic Leukemia and Childhood Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Targeted Therapy732 topics
  2. Cancer Genomics541 topic
  3. Mutational Signatures541 topic
  4. Prognostic Factors442 topics
  5. Immune Checkpoint Blockade291 topic
  6. PD-1 and PD-L1291 topic
  7. Acute Lymphoblastic Leukemia241 topic
  8. Childhood Cancer241 topic
  9. AML201 topic
  10. Acute Myeloid Leukemia201 topic
  11. ALK Inhibitors191 topic
  12. EGFR Mutations191 topic
  13. Microsatellite Instability191 topic
  14. Molecular Characterization191 topic
  15. Breast Cancer181 topic
  16. Classification181 topic
  17. HER2181 topic
  18. Lymphoma181 topic

Where does Matthew James Oberley work?

Matthew James Oberley's main affiliation in the publication record is Caris Life Sciences (United States), United States.

How many publications and citations does Matthew James Oberley have?

OpenAlex counts 377 works and 3,477 citations for Matthew James Oberley, an h-index of 31, ranking #235,415 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Matthew James Oberley. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.